Skip to main content

Table 6 Comparison time-course serum profiles PR vs. no PR

From: Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling

m/z

p-value

peptide ID

1616.6366

0.007392

P-FPA

1596.189

0.011159

 

872.4325

0.018308

 

3215.1939

0.028873

 

1631.2111

0.040931

 
  1. Five peaks were significantly differential comparing NSCLC patients with a partial response versus patients with stable or progressive disease, using three time points: pre-treatment, after two cycles of treatment and end of treatment. Ordered by p-value.
  2. Abbreviation: P-FPA: phospho-fibrinopeptide A
Back to article page

Proteome Science

ISSN: 1477-5956